Nephros, Inc.
NEPH
$3.42
-$0.13-3.66%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 38.47% | 18.93% | -5.99% | -8.27% | -4.73% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 38.47% | 18.93% | -5.99% | -8.27% | -4.73% |
| Cost of Revenue | 29.06% | 13.14% | -11.56% | -8.59% | -15.83% |
| Gross Profit | 44.22% | 22.46% | -2.05% | -8.03% | 3.60% |
| SG&A Expenses | 5.23% | -22.36% | -19.47% | -13.31% | 0.85% |
| Depreciation & Amortization | 18.18% | -33.33% | -38.18% | -37.04% | -38.89% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.82% | -8.97% | -16.05% | -10.33% | -7.02% |
| Operating Income | 383.00% | 148.84% | 201.48% | 27.13% | 34.64% |
| Income Before Tax | 430.18% | 155.66% | 200.55% | 33.26% | 44.77% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 430.18% | 153.36% | 200.55% | 33.26% | 44.77% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 430.18% | 153.36% | 200.55% | 33.26% | 44.77% |
| EBIT | 383.00% | 148.84% | 201.48% | 27.13% | 34.64% |
| EBITDA | 465.06% | 158.86% | 262.59% | 26.18% | 34.13% |
| EPS Basic | 426.71% | 153.04% | 200.00% | 34.52% | 45.79% |
| Normalized Basic EPS | 425.74% | 155.38% | 199.08% | 34.60% | 45.70% |
| EPS Diluted | 350.00% | 153.04% | 187.00% | 34.52% | 33.33% |
| Normalized Diluted EPS | 425.74% | 155.38% | 199.08% | 34.60% | 45.70% |
| Average Basic Shares Outstanding | 0.94% | 0.54% | 0.80% | 2.06% | 1.98% |
| Average Diluted Shares Outstanding | 1.09% | 0.65% | 1.15% | 2.06% | 1.98% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |